Okogen.com


Keyword Suggestion

Okogen
Onkogene
Ocugen
Kogan
Oncogene
Oko genially
Okagen
Ok agencia
Ocogen
Oko genially klasa 7
Okofen france



Domain Informations

Okogen.com lookup results from whois.directnic.com server:
  • Domain created: 2015-05-21T16:31:45Z
  • Domain updated: 2024-04-09T22:22:40Z
  • Domain expires: 2026-05-21T16:31:45Z 1 Year, 192 Days left
  • Website age: 9 Years, 173 Days
  • Registrar Domain ID: 1931059762_DOMAIN_COM-VRSN
  • Registrar Url: http://www.directnic.com
  • Registrar WHOIS Server: whois.directnic.com
  • Registrar Abuse Contact Email:
  • Registrar Abuse Contact Phone: Not Available
  • Name server:
    • DAN.NS.CLOUDFLARE.COM
    • EMMA.NS.CLOUDFLARE.COM

Network
  • inetnum : 141.193.213.0 - 141.193.213.255
  • name : WPENG
  • handle : NET-141-193-213-0-1
  • status : Direct Allocation
  • created : 2020-03-20
  • changed : 2020-07-14
Owner
  • organization : WPEngine, Inc.
  • handle : WPENG
  • address : Array,Austin,TX,78701,US
Technical support
Abuse
Domain Provider Number Of Domains
godaddy.com 286730
namecheap.com 101387
networksolutions.com 69118
tucows.com 52617
publicdomainregistry.com 39120
whois.godaddy.com 32793
enomdomains.com 23825
namesilo.com 21429
domains.google.com 21384
cloudflare.com 20573
gmo.jp 18110
name.com 17601
fastdomain.com 14708
register.com 13495
net.cn 12481
ionos.com 12416
ovh.com 12416
gandi.net 12305
registrar.amazon.com 12111


Host Informations

  • IP address: 141.193.213.11
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Check all domain's dns records


See Web Sites Hosted on 141.193.213.11

Fetching Web Sites Hosted


Site Inspections


Port Scanner (IP: 141.193.213.11)

 › Ftp: 21
 › Ssh: 22
 › Telnet: 23
 › Smtp: 25
 › Dns: 53
 › Http: 80
 › Pop3: 110
 › Portmapper, rpcbind: 111
 › Microsoft RPC services: 135
 › Netbios: 139
 › Imap: 143
 › Ldap: 389
 › Https: 443
 › SMB directly over IP: 445
 › Msa-outlook: 587
 › IIS, NFS, or listener RFS remote_file_sharing: 1025
 › Lotus notes: 1352
 › Sql server: 1433
 › Point-to-point tunnelling protocol: 1723
 › My sql: 3306
 › Remote desktop: 3389
 › Session Initiation Protocol (SIP): 5060
 › Virtual Network Computer display: 5900
 › X Window server: 6001
 › Webcache: 8080


Spam Check (IP: 141.193.213.11)

 › Dnsbl-1.uceprotect.net:
 › Dnsbl-2.uceprotect.net:
 › Dnsbl-3.uceprotect.net:
 › Dnsbl.dronebl.org:
 › Dnsbl.sorbs.net:
 › Spam.dnsbl.sorbs.net:
 › Bl.spamcop.net:
 › Recent.dnsbl.sorbs.net:
 › All.spamrats.com:
 › B.barracudacentral.org:
 › Bl.blocklist.de:
 › Bl.emailbasura.org:
 › Bl.mailspike.org:
 › Bl.spamcop.net:
 › Cblplus.anti-spam.org.cn:
 › Dnsbl.anticaptcha.net:
 › Ip.v4bl.org:
 › Fnrbl.fast.net:
 › Dnsrbl.swinog.ch:
 › Mail-abuse.blacklist.jippg.org:
 › Singlebl.spamgrouper.com:
 › Spam.abuse.ch:
 › Spamsources.fabel.dk:
 › Virbl.dnsbl.bit.nl:
 › Cbl.abuseat.org:
 › Dnsbl.justspam.org:
 › Zen.spamhaus.org:


Email address with okogen.com

Found 1 emails of this domain
1. [email protected]

Recent Searched Sites

E-finspor.com (13 seconds ago) / US

Kambaniru.sumbatimurkab.go.id (35 seconds ago) / US

Ibsedu.bg (1 mins ago) / US

Okogen.com (1 seconds ago) / US

35.163.45.65 (32 seconds ago) / US

Satilla.org (23 seconds ago) / US

Sgni.in (3 seconds ago) / CL

Htfr.com (32 seconds ago) / GB

Admin.cressi.com (11 seconds ago) / IE

182.162.17.157 (32 seconds ago) / KR

Yashhv.com (22 seconds ago) / US

Krasdalefoods.com (31 seconds ago) / US

Champion3.shate-mag.by (13 seconds ago) / BY

Gr8pvine.com (25 seconds ago) / US

Asaplinen.com (6 seconds ago) / US

Hoteliers.guru (17 seconds ago) / SG

Tokker.ru (3 seconds ago) / EE

Slide-share.ru (37 seconds ago) / US

En.erocool1.com (12 seconds ago) / US

Ostrichlandusa.com (7 seconds ago) / US

Websites Listing

We found Websites Listing below when search with okogen.com on Search Engine

Contact Us - Okogen

2022-03-08  · Okogen, Inc. 332 Encinitas Blvd. Suite 102 Encinitas, CA 92024 USA. Australia. Okogen Pty Ltd 31 Queen St, 9th Floor Melbourne, VIC 3000 AUS. Email Us. [email protected]. Latest News & Press. View All News. Press Release. Okogen, Inc., Announces Ophthalmology Industry Veteran Joshua Moriarty as New Chief Executive Officer …

Okogen.com

Okogen, Inc. Email Formats & Employee Phones — Biotech ...

Contact and general information about Okogen, Inc. company. Email formats & phone numbers of Okogen, Inc. 1-10 employees. Biotech

Signalhire.com

Okogen, Inc. | LinkedIn

Okogen, Inc. | 151 followers on LinkedIn. Developing Innovative Therapeutics for Ocular Diseases | Okogen, Inc., is a private biotechnology company focused on novel therapeutics to treat unmet need in ophthalmic infectious diseases.

Ca.linkedin.com

Okogen, Inc. Information | Okogen, Inc. Profile

Okogen, Inc., is a private biotechnology company focused on novel therapeutics to treat unmet need in ophthalmic infectious diseases. View Top Employees from Okogen, Inc.

Rocketreach.co

Okogen - Home | Facebook

Email or phone: Password: Forgot account? Home. Posts. Reviews. Photos. Community. About. See more of Okogen on Facebook. Log In. or. Create new account. See more of Okogen on Facebook. Log In . Forgot account? or. Create new account. Not now. Okogen. Biotechnology Company in Encinitas, California. Community See All. 17 people like this. 21 people follow …

Facebook.com

Okogen – MRCF

Okogen is a biotechnology company focused on developing therapeutics to help patients with ophthalmic diseases. The lead candidate is OKG-0301, a potent, broad-spectrum antiviral that functions intracellularly to inhibit viral replication and reduce inflammation. These mechanisms of action provide opportunity to address adenoviral infections of the eye as well as other classes …

Mrcf.com.au

OKOGEN PTY. LTD., n/a 2021 find contacts: address, phone ...

OKOGEN PTY. LTD., n/a 2021: full company data. Find address OKOGEN PTY. LTD., phone, email, website credits, responds, OKOGEN PTY. LTD. company information ...

Asic4.com

US company Okogen launches Australian clinical trial - Biotech

2019-01-31  · The RUBY trial will evaluate the safety and efficacy of Okogen’s lead candidate, OKG-0301, in the treatment of acute adenoviral conjunctivitis (commonly known as viral conjunctivitis). The trials will take place at seven clinical sites in Sydney, Melbourne, Albury, Adelaide, Perth and Hobart. Adenoviral conjunctivitis is a highly contagious disease that …

Biotechdispatch.com.au

Okogen, Inc. - Overview, Competitors, and Employees ...

Okogen, Inc., is a private biotechnology company focused on novel therapeutics to treat unmet need in ophthalmic infectious diseases.

Apollo.io

Orgenesis Inc (ORGS-Q) Quote - Press Release - The Globe ...

Okogen is a clinical-stage, specialty biotechnology company focused on developing therapeutics to help patients with ocular diseases. The company’s lead development candidate, OKG-0502, is …

Theglobeandmail.com

Okogen Inc - Company Profile and News - Bloomberg Markets

Okogen, Inc. operates as a biotechnology company. The Company discovers, develops, and commercializes therapies for the treatment of diseases. Okogen serves customers in …

Bloomberg.com

OCGN: Ocugen Inc - Stock Price, Quote and News - CNBC

2022-04-01  · Get Ocugen Inc (OCGN:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

Cnbc.com

Okogen, Inc., Announces Ophthalmology Industry Veteran ...

2022-03-08  · San Diego, CA and Melbourne, AUS – March 8, 2022 – Okogen, an ophthalmic biotechnology company, today announced the appointment of Joshua Moriarty as the new Chief Executive Officer (CEO). Mr ...

Digitaljournal.com

Okogen, Inc. Employee Details, Technology Stack and More ...

Find useful insights on Okogen, Inc.’s employee, technology stack, location, news alerts and more at Slintel. Use Slintel to connect with top decision-makers at Okogen, Inc..

Slintel.com

Orgenesis Achieves Multiple Ranpirnase Development Milestones

2021-07-06  · Okogen is a clinical-stage, specialty biotechnology company focused on developing therapeutics to help patients with ocular diseases. The company’s lead development candidate, OKG-0502, is a ...

Finance.yahoo.com

Okogen receives $10 million in Series A funding - Healio

2018-02-27  · Okogen has received $10 million in Series A funding from Brandon Capital’s Medical Research Commercialisation Fund in order to advance the development of its viral conjunctivitis treatment ...

Healio.com

Orgenesis Inc (ORGS-Q) Quote - Press Release - The Globe ...

Detailed price information for Orgenesis Inc (ORGS-Q) from The Globe and Mail including charting and trades.

Theglobeandmail.com


Domains Expiration Date Updated

Site Provider Expiration Date
pokerren.com godaddy.com -1 Years, -153 Days
beauty-girl-naked.xyz namesilo.com -2 Years, -114 Days
freegamesmax.com ascio.com -2 Years, -120 Days
yovole.com bizcn.com 3 Years, 106 Days
anfusoimaging.com godaddy.com -2 Years, -72 Days
maniadegibi.com domains.google.com -1 Years, -298 Days
aoe.wiki namecheap.com -2 Years, -170 Days
confort-electro.com namesrs.com -2 Years, -233 Days
forward-sms-to-rest-api.com namecheap.com -2 Years, -37 Days
henryadvancedorthodontics.com godaddy.com 2 Years, 172 Days

    Browser All

    .com4.3M domains   

    .org1M domains   

    .edu40.8K domains   

    .net622.4K domains   

    .gov15.9K domains   

    .us31K domains   

    .ca45.2K domains   

    .de562.1K domains   

    .uk466.3K domains   

    .it35.4K domains   

    .au46.9K domains   

    .co34.3K domains   

    .biz13.9K domains   

    .info36.3K domains   

    .fr37.9K domains   

    .eu25K domains   

    .ru196.9K domains   

    .ph5.7K domains   

    .in54.5K domains   

    .vn19K domains   

    .cn40.9K domains   

    .ro19.6K domains   

    .ch12K domains   

    .at10.3K domains   

    Browser All